- 同
- CytoGam
WordNet
- secure against; "immune from taxation as long as he resided in Bermuda"; "immune from criminal prosecution"
- a person who is immune to a particular infection
- relating to or conferring immunity (to disease or infection) (同)resistant
- (usually followed by `to'
- relating to the condition of immunity; "the immune system"
- a family of proteins found in blood and milk and muscle and in plant seed
- any of a group of herpes viruses that enlarge epithelial cells and can cause birth defects; can affect humans with impaired immunological systems (同)CMV
PrepTutorEJDIC
- 免疫の / 《補語にのみ用いて》(影響・攻撃・義務・税などを)免れている《+『against』(『from, to』)+『名』》
- グロブリン(動植物組織内の純蛋白(たんぱく)質の総称)
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 肺移植患者におけるサイトメガロウイルス感染の予防prevention of cytomegalovirus infection in lung transplant recipients [show details]
…three months after the antirejection therapy has been completed . Use of adjunctive cytomegalovirus immune globulin (CytoGam) is controversial. While some experts do add CMV immune globulin to antiviral …
- 2. 腎移植レシピエントが発症したサイトメガロウイルス感染症の臨床症状、診断、マネージメントclinical manifestations diagnosis and management of cytomegalovirus disease in kidney transplant recipients [show details]
…alternative regimen, further reduction of immunosuppression, and/or adjunctive treatment with cytomegalovirus immune globulin (CytoGam, CMV Ig) or intravenous immune globulin (IVIG). The duration of therapy depends …
- 3. 肺移植レシピエントにおけるサイトメガロウイルス感染の臨床症状、診断、および治療clinical manifestations diagnosis and treatment of cytomegalovirus infection in lung transplant recipients [show details]
…less sensitive assay). The minimum duration of therapy is two weeks . The addition of cytomegalovirus immune globulin (CytoGam) to antiviral therapy might theoretically improve treatment response and, while…
- 4. 原発性免疫不全症:マネージメントの概要primary immunodeficiency overview of management [show details]
- 5. 免疫グロブリン静脈内投与(IVIG)療法の概要overview of intravenous immune globulin ivig therapy [show details]
…include the following: Various products (eg, varicella-zoster immune globulin [VariZIG]; cytomegalovirus immune globulin [CMVIG]) may be given to hematopoietic cell transplantation (HCT) recipients who have…
English Journal
- Reduced Incidence of Cytomegalovirus Infection in Kidney Transplant Recipients Receiving Everolimus and Reduced Tacrolimus Doses.
- Tedesco-Silva H1, Felipe C1, Ferreira A1, Cristelli M1, Oliveira N1, Sandes-Freitas T1, Aguiar W2, Campos E3, Gerbase-DeLima M3, Franco M4, Medina-Pestana J1.
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.Am J Transplant.2015 Oct;15(10):2655-64. doi: 10.1111/ajt.13327. Epub 2015 May 18.
- This study compared the incidence of CMV infection/disease in de novo kidney transplant recipients receiving everolimus or mycophenolate and no CMV pharmacological prophylaxis. We randomized 288 patients to receive a single 3 mg/kg dose of antithymocyte globulin, tacrolimus, everolimus, and predni
- PMID 25988935
- Human antibody technology and the development of antibodies against cytomegalovirus.
- Ohlin M1, Söderberg-Nauclér C2.
- Molecular immunology.Mol Immunol.2015 Oct;67(2 Pt A):153-70. doi: 10.1016/j.molimm.2015.02.026. Epub 2015 Mar 20.
- Cytomegalovirus (CMV) is a virus that causes chronic infections in a large set of the population. It may cause severe disease in immunocompromised individuals, is linked to immunosenescence and implied to play an important role in the pathogenesis of cardiovascular diseases and cancer. Modulation of
- PMID 25802091
- Cytomegalovirus reactivation after autologous stem cell transplantation in myeloma and lymphoma patients: A single-center study.
- Marchesi F1, Pimpinelli F1, Gumenyuk S1, Renzi D1, Palombi F1, Pisani F1, Romano A1, Spadea A1, Papa E1, Canfora M1, Ensoli F1, Mengarelli A1.
- World journal of transplantation.World J Transplant.2015 Sep 24;5(3):129-36. doi: 10.5500/wjt.v5.i3.129.
- AIM: To determine the incidence of and the risk factors for cytomegalovirus (CMV) symptomatic infection and end-organ disease after autologous stem cell transplantation (ASCT).METHODS: A total of 327 consecutive non CD34(+) selected autografts performed from the Hematology and Stem Cell Transplantat
- PMID 26421265
Japanese Journal
- Ventures 造血幹細胞移植における静注用グロブリン
- ガンシクロビルとガンマグロブリン併用療法が著効した先天性サイトメガロウイルス感染症の1例
- 佐々木 照子,杉本 健郎,西田 直樹,荒木 敦,安原 昭博
- 日本小児科学会雑誌 102(10), 1098-1101, 1998-10-01
- NAID 10005956916
Related Links
- Easy to read patient leaflet for cytomegalovirus immune globulin. Includes indications, proper use, special instructions, precautions, and possible side effects. ... How to use cytomegalovirus immune globulin: Use cytomegalovirus ...
- CYTOGAM - human cytomegalovirus immune globulin liquid CSL Behring AGCytogam ® Cytomegalovirus Immune Globulin Intravenous (Human) Liquid Formulation Solvent Detergent Treated R x only DESCRIPTION Cytogam ® ...
Related Pictures
★リンクテーブル★
[★]
- 関
- cytomegalovirus immune globulin
[★]
- 同
- cytomegalovirus immune globulin
[★]
- 関
- immunisation、immunise、immunity、immunization、immunize、immuno、immunologic
[★]
- 関
- globule、globulus、spherule
[★]
免疫グロブリン Ig immunoglobulins Igs
[★]
サイトメガロウィルス, CMV